American Oriental Bioengineering Total Liabilities

American Oriental Bioengineering (AOBI) currently reports a total liabilities of $140M as of September 2013. That compares with $140M in the prior-year period — up 3.1% year over year. Use the charts on this page to explore American Oriental Bioengineering's total liabilities history and peer comparisons.

American Oriental Bioengineering's total liabilities increased from $140M to $140M — a 3.1% year-over-year increase (period ending September 2013). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

American Oriental Bioengineering reported $140M in total liabilities as of September 2013. That compares with $140M in the prior-year period — up 3.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $140M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for American Oriental Bioengineering, and consider following AOBI for alerts when major investors trade the stock.

American Oriental Bioengineering is classified in the Healthcare sector. On total liabilities, it currently shows $140M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AOBI with unrelated industries.